Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease

Intra- and inter-laboratory variability of cerebrospinal fluid (CSF) biomarker analyses remains an important issue. We investigated the clinical-diagnostic impact of CSF biomarker concentration shifts in mild cognitive impairment (MCI) and autopsy-confirmed Alzheimer’s disease (AD) dementia patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Alzheimers Dis
Autors principals: Niemantsverdriet, Ellis, Goossens, Joery, Struyfs, Hanne, Martin, Jean-Jacques, Goeman, Johan, De Deyn, Peter Paul, Vanderstichele, Hugo, Engelborghs, Sebastiaan
Format: Artigo
Idioma:Inglês
Publicat: IOS Press 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4927863/
https://ncbi.nlm.nih.gov/pubmed/26836187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-150953
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars